Suppr超能文献

胃肠道检测组合的临床决策支持

Clinical decision support for gastrointestinal panel testing.

作者信息

Saif Nadia T, Dooley Cara, Baghdadi Jonathan D, Morgan Daniel J, Coffey K C

机构信息

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.

Department of Medicine, Veteran's Affairs (VA) Maryland Healthcare System, Baltimore, MD, USA.

出版信息

Antimicrob Steward Healthc Epidemiol. 2024 Feb 8;4(1):e22. doi: 10.1017/ash.2024.15. eCollection 2024.

Abstract

OBJECTIVE

This study aimed to assess the impact of clinical decision support (CDS) to improve ordering of multiplex gastrointestinal polymerase chain reaction (PCR) testing panel ("GI panel").

DESIGN

Single-center, retrospective, before-after study.

SETTING

Tertiary care Veteran's Affairs (VA) Medical Center provides inpatient, outpatient, and residential care.

PATIENTS

All patients tested with a GI panel between June 22, 2022 and April 20, 2023.

INTERVENTION

We designed a CDS questionnaire in the electronic medical record (EMR) to guide appropriate ordering of the GI panel. A "soft stop" reminder at the point of ordering prompted providers to confirm five appropriateness criteria: 1) documented diarrhea, 2) no recent receipt of laxatives, 3) is not the leading suspected cause of diarrhea, 4) time period since a prior test is >14 days or prior positive test is >4 weeks and 5) duration of hospitalization <72 hours. The CDS was implemented in November 2022.

RESULTS

Compared to the pre-implementation period ( = 136), fewer tests were performed post-implementation ( = 92) with an IRR of 0.61 ( = 0.003). Inappropriate ordering based on laxative use or undocumented diarrhea decreased (IRR 0.37, = 0.012 and IRR 0.25, = 0.08, respectively). However, overall inappropriate ordering and outcome measures did not significantly differ before and after the intervention.

CONCLUSIONS

Implementation of CDS in the EMR decreased testing and inappropriate ordering based on use of laxatives or undocumented diarrhea. However, inappropriate ordering of tests overall remained high post-intervention, signaling the need for continued diagnostic stewardship efforts.

摘要

目的

本研究旨在评估临床决策支持(CDS)对改善多重胃肠道聚合酶链反应(PCR)检测组合(“GI组合”)医嘱开具情况的影响。

设计

单中心、回顾性前后对照研究。

背景

三级医疗退伍军人事务(VA)医疗中心提供住院、门诊和住院护理服务。

患者

2022年6月22日至2023年4月20日期间所有接受GI组合检测的患者。

干预措施

我们在电子病历(EMR)中设计了一份CDS问卷,以指导GI组合检测的合理医嘱开具。医嘱开具时的“软停止”提醒促使医生确认五项合理性标准:1)有记录的腹泻;2)近期未使用泻药;3)不是腹泻的主要疑似病因;4)上次检测后时间间隔>14天或上次检测阳性后时间间隔>4周;5)住院时间<72小时。CDS于2022年11月实施。

结果

与实施前阶段(n = 136)相比,实施后进行的检测较少(n = 92),发病率比值比(IRR)为0.61(P = 0.003)。基于泻药使用或无记录腹泻的不适当医嘱开具情况有所减少(IRR分别为0.37,P = 0.012和IRR 0.25,P = 0.08)。然而,干预前后总体不适当医嘱开具情况和结果指标没有显著差异。

结论

在电子病历中实施CDS减少了检测以及基于泻药使用或无记录腹泻的不适当医嘱开具情况。然而,干预后检测的不适当医嘱开具情况总体仍然很高,这表明需要持续进行诊断管理工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5178/10897720/3c69a0424872/S2732494X24000159_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验